The FDA has authorized an expanded access program that will allow for the use of a recombinant bacillus Calmette-Guerin product.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback